Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or follow us at @agenus_bio. Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
Looking for a particular Agenus employee's phone or email?
The Agenus annual revenue was $160.4 million in 2026.
Garo Armen is the Chairman and CEO of Agenus.
149 people are employed at Agenus.
Agenus is based in Lexington, Massachusetts.
The NAICS codes for Agenus are [33, 32, 333, 3332, 325].
The SIC codes for Agenus are [87, 28, 873, 283].